As Exclusive Distributor for NIUMAG, we are pleased to introduce you to their New MRI Spectrometer, model:
AniMR
Tel / Fax: +34 91 3555803
Office: 09:30 - 17:30 hours
from Monday to Friday
MRI Spectrometer, model AniMR

El MRI Spectrometer, model AniMR
Introduction
MRI has been widely used in life science giving unique contrast information, which provides a precise and intuitional method for measurement of live samples. The NIUMAG productions as pow-erful, non-destructive tools have been used for scanning and phenotyping mouse models in research laboratories. Besides MRI our equipments also offers analysis of whole body composition providing a precise method for measurement of muscle, fat, and fluids in live mice and rats and even larger sized animals.
Niumag has developed a low cost MRI suitable for small animal veterinary diagnosis (e.g. tumor, lung disease, tendon damage, etc), for placing in animal hospitals Small animal models of human diseases constitute a major step for evaluation of new therapies. Preclinical imaging provides quantitative data, allowing in vivo studies of therapy strategies. MRI is a non-invasive technique suitable to image soft tissues like muscle, brain and other organs. With this technique being available for humans, it should therefore also be suitable to image other or-ganisms. Non-invasive MRI tumor imaging shows high resolutions between normal tissues to tumors which provide a method to detect the tumorigenesis and monitor the tumor development rate Whole Body Composition Analyzer based on TD-NMR provides a precise method for measurement of Lean Tissue, Fat, and Fluid in live mice and rats. As a powerful, non-destructive and non-invasive tool for characterizing, screening and phenotyping mouse models in research laboratories, It has become the industrial standard for fat and lean measurement in live mice with installations in major diabetes and obesity research institutes and universities. The key feature is:that longitudinal studies become possible, because the animal is carefully handled without anesthesia. Organ transplants are a commonly accepted therapeutic modality for treatment of endstage patients. However, long-term graft survival is still threatened by acute and chronic rejection, as well as by complications such as infection caused by immunosuppression. Thus, a proper evaluation of the progression of graft rejection could have a significant impact on the management and outcome of transplant patients. Although numerous techniques have been used for the detection of organ allograft rejection, development of special, sensitive, and non-invasive methods for the diagnosis of rejection is still a major challenge. Biopsy is generally accepted as the “gold standard” for diagnosing graft rejection. However, this procedure is not only prone to sampling errors, but it also exposes patients to the risks of possible bleeding and infection. Dietary analysis finds out how food affects the body composition.
MRI is a promising technology in that it can provide non-invasive imaging with sub-millimeter resolution and high tissue contrast. This has been applied to the imaging and relaxation analysis of ex vivo and in vivo research on various compounds (such as cholesterol, fat, protein, etc) taken in diets. During the last years, NMR spectroscopy and NMR imaging (MRI) have been increasingly used to study drug effects in vitro and in vivo. However, high installation and running costs of the commonly used superconducting magnet technology limits the application range and prevents the further spread of this non-invasive technology. NIUMAG productions use permanent magnets and is much less cost intensive. The usefulness and capabilities of MRI are generally well appreci-ated in the drug delivery community. The majority of the in vitro ap-plications of MRI are linked to the monitoring of the hydration, swelling and erosion of matrix tablets. Preclinical in vivo applica-tions of MRI on mice and rats include studies of the fate of biode-gradable polymers, liposomes, mucoadhesive polymers and cells. The process to discover and to bring a drug to market is complex, costly and long, requiring in average 12 years. It is expected that im-provements in the chemistry should reduce the attrition rate, thus in-creasing the success rate and, perhaps, reducing the development costs at the same time. A much better understanding of this perform-ance relationship is needed to develop predictive algorithms that will increase the survival rate of compounds in clinical trials. The devel-opment of imaging strategies meets the requirements. such as immunology, development, endocrinology, etc. For prices or addional information of the MRI Spectrometer, model AniMR, from Niumag, please call us atSmall animal veterinary diagnosis
Preclinical live animal physiology and pathology research
Untouched visceral anatomy
Tumor Research
Diabetes and obesity research
Graft rejection detection in organ transplants
Small animal nutrition
Pharmaceutical field
Non-invasive monitoring of drug delivery processes
Preclinical live animal drug discovery and toxicity ( such as Diabetes drug effect and toxicity)
Specifications AniMR-150
Other fields
Images of the AniMR 150





+34 91 355 58 03 or send us an e-mail to :
Técnicas Asociadas de Instrumentación, S.L.